Background Rheumatoid arthritis (RA) is associated with inflammation-driven hypercoagulability and increased venous ...
Background Systemic lupus erythematosus (SLE) predominantly affects women of childbearing age and is often associated with ...
Background Approximately 10%–20% of patients with Kawasaki disease (KD) are resistant to intravenous immunoglobulins (IVIG) ...
Objectives The intrauterine environment may influence childhood immune-mediated disease risk. We investigated whether ...
It is postulated that fibromyalgia reflects a neurobiologically rooted imbalance between overactivated threat systems and ...
Objective To test whether ultrasonography of patients with rheumatoid arthritis (RA) in the American College of ...
Objective This systematic literature review (SLR) aims to update the evidence regarding therapeutic strategies in difficult-to-treat rheumatoid arthritis (D2T RA), building on the previous SLR ...
Objectives The oral microbiome plays a critical role in modulating systemic inflammation, partly through its interactions with the gut microbiome. Although gut microbiome dysbiosis has been implicated ...
Objectives Avacopan, an oral C5a receptor antagonist, is approved for treatment of severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in combination with rituximab or ...
Psoriatic arthritis (PsA) is a chronic inflammatory disease characterised by joint involvement, significant impact on quality of life and frequently linked with obesity, metabolic syndrome and ...
Objective Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly recognised for benefits beyond glycaemic control, including anti-inflammatory, anti-atherogenic and potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results